• Otofa ear drops 10 ml

Otofa ear drops  (rifamicin) 10 ml

Description OTOFA cap. ush. 20,000 IU / ml vial. 10 ml:
OTOFA (OTOFA)

RIFAMYCINUM S02A A12
Lab. Bouchara-Recordati

Structure and Composition:

Cap. ush. 20,000 IU / ml vial. 10 ml
 
Rifamycin sodium 26 mg / ml

Other ingredients: lithium hydroxide, macrogol 400, ascorbic acid, sodium edetate, purified water, potassium metabisulfite.

26 mg corresponding to 20 000 IU of sodium rifamycin.

Pharmacological properties: The Pharmacodynamics. Rifamycin exhibits antimicrobial activity against most gram-positive and Gram-negative microorganisms that cause the development of infectious and inflammatory diseases of the middle ear. Mechanism of action of rifamycin due to the formation of a stable complex with DNA-dependent RNA polymerase, which prevents bacterial growth.
Pharmacokinetics. Studies on pharmacokinetics was not performed.

INDICATIONS: chronic otitis media in exacerbation, including the presence of persistent perforation of the tympanic membrane, isolated purulent lesions of the eardrum; state after surgical interventions on the middle ear.

APPLICATION: adults buried in the ear canal to 5 drops 2 times a day or fill pp medication for a few minutes 2 times a day for a drug can be used for washing the tympanic cavity through the attic cannula.
Children buried in the ear canal to 3 drops 2 times a day or fill pp medication for a few minutes 2 times a day.
Duration of treatment - usually no more than 7-10 days.
Before using the ear drops recommended to warm the bottle by holding it in his hand, to avoid discomfort caused by the hit of cold liquid into your ear.

CONTRAINDICATIONS: Hypersensitivity to the drug.

SIDE EFFECTS: allergic reactions are possible. Probably dying of the eardrum in pink.

SPECIAL INSTRUCTIONS: During the application should avoid touching the tip of the dropper as fingers and ears to reduce the risk of infection. The simultaneous use with any other drugs for the topical treatment is not recommended. Local application of antibacterial drugs can cause sensitization to the active substances and lead to systemic reactions. Must immediately stop using the product if you have experienced a rash or other systemic manifestations of allergic reactions. If symptoms persist after 10 days of treatment, it is necessary to review treatment strategy.
Necessary to prevent drug contact with clothing, because p-p can leave stains on the fabric.
Use during pregnancy and lactation
Adequate and well controlled clinical studies on the safety of the drug during pregnancy has not been performed, but given the fact that the blood gets a small amount of the drug, as well as taking into account the results of test compounds that belong to the rifamycin group, the drug can be used during pregnancy.
Given that the breast milk gets a small amount of the drug, women who use ear drops, based on rifamycin may use the drug while breastfeeding.
Children. Applied by a doctor for treatment of children with no age restrictions.
Ability to influence the reaction rate on driving and operating other machinery. No effect.

INTERACTION: clinically significant interactions were found.

OVERDOSE: Due to the low degree of absorption into the systemic circulation overdose is unlikely.

Storage conditions: at 25 ° C.

Otofa ear drops 10 ml

  • Product Code: 67
  • Availability: In Stock
  • $28.00

  • Ex Tax: $28.00

Tags: Otofa ear drops 10 ml